awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38216590-0674D8FF-3323-42C9-9E75-B13545D2B68A
Q38216590-0674D8FF-3323-42C9-9E75-B13545D2B68A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38216590-0674D8FF-3323-42C9-9E75-B13545D2B68A
Targeting the oncogenic Met receptor by antibodies and gene therapy.
P2860
Q38216590-0674D8FF-3323-42C9-9E75-B13545D2B68A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38216590-0674D8FF-3323-42C9-9E75-B13545D2B68A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
776cba1a05b6c16f9c57e0c22d8ba725114c28df
P2860
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma